...
首页> 外文期刊>Journal of arrhythmia. >Successful intraprocedural anticoagulation with bivalirudin during pulmonary vein isolation in a patient with known heparin-induced thrombocytopenia type II
【24h】

Successful intraprocedural anticoagulation with bivalirudin during pulmonary vein isolation in a patient with known heparin-induced thrombocytopenia type II

机译:已知肝素诱发的II型血小板减少症患者在肺静脉隔离过程中成功应用比伐卢定抗凝

获取原文
           

摘要

We report the case of a 56-year-old female who presented with symptomatic paroxysmal atrial fibrillation. Anamnestic heparin-induced thrombocytopenia (HIT) type II was suspected, and a rapid diagnostic test showed antibodies against platelet factor 4. The heparin-induced platelet activation-assay was negative. Radiofrequency pulmonary vein isolation with intraprocedural anticoagulation using bivalirudin was ultimately performed. Dosing was controlled by monitoring the activated clotting time. Post-procedural blood tests were normal. There were no thromboembolic or bleeding events. Bivalirudin is a therapeutic option for anticoagulation during pulmonary vein isolation procedures in patients with a history of HIT type II.
机译:我们报告一例出现症状性阵发性心房颤动的56岁女性的病例。怀疑有肝炎性肝素诱导的II型血小板减少症(HIT),并且快速诊断测试显示抗血小板因子4的抗体。肝素诱导的血小板活化测定为阴性。最终采用比伐卢定进行射频肺静脉隔离和术中抗凝。通过监测活化的凝血时间来控制剂量。术后血液检查正常。没有血栓栓塞或出血事件。比伐卢定是具有II型HIT病史的患者在肺静脉隔离手术期间抗凝的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号